Ocugen to commercialise Covaxin in Mexico

City-based pharma major Bharat Biotech’s US partner Ocugen, Inc. has got the permission to commercialise  Covid vaccine Covaxin in Mexico.

published on : 19th April 2022

Bharat Biotech expands Covaxin pact with Ocugen to enter North America market

The Hyderabad-based pharma major has also sought EUA for use of Covaxin for children in the 2-18 years age group in Mexico.

published on : 18th April 2022

Emergency use authorization request filed with FDA for paediatric use of Bharat Biotech's Covaxin

The submission is based on the results of a Phase 2/3 paediatric clinical trial conducted by Bharat Biotech in India with 526 children 2-18 years of age.

published on : 5th November 2021